Jushi Holdings (JUSHF) Capital Expenditures (2021 - 2026)
Jushi Holdings' (JUSHF) quarterly Capital Expenditures came in at $1.6 million in Q1 2026, down 24.12% year-on-year from $2.1 million in Q1 2025, and up 525.0% on a QoQ basis from -$376000.0 in Q4 2025.
Jushi Holdings (JUSHF) Capital Expenditures (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has 6 years of Capital Expenditures data on file, last reported at $1.6 million in Q1 2026.
- On a quarterly basis, Capital Expenditures fell 24.12% year-over-year to $1.6 million in Q1 2026; TTM through Mar 2026 was $1.9 million, a 53.06% decrease from a year earlier, with the FY2025 full-year figure at $2.4 million, down 17.78% from the prior year.
- Capital Expenditures for Q1 2026 stood at $1.6 million, up from -$376000.0 in the prior quarter.
- Over the last five years, Capital Expenditures for JUSHF reached as high as $24.9 million in Q1 2022 and fell as low as -$17.5 million in Q2 2022.
- Historically, Capital Expenditures has averaged $1.5 million across 5 years, with a median of $770000.0 in 2024.
- Across the five-year window, Capital Expenditures jumped 269.59% in 2024 and tumbled 203.58% in 2025, its largest moves.
- Year by year, Capital Expenditures stood at -$3.3 million in 2022, then surged by 172.51% to $2.4 million in 2023, then slumped by 84.61% to $363000.0 in 2024, then tumbled by 203.58% to -$376000.0 in 2025, then soared by 525.0% to $1.6 million in 2026.
- Per Business Quant data, the three most recent Capital Expenditures figures were $1.6 million in Q1 2026, -$376000.0 in Q4 2025, and $110000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 168.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 110.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.95 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 99.60 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 39.90 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 51.00 Mn |
| 10 | Jushi Holdings | 81.25 Mn | 41.54 Mn | 29.88 Mn | 1.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.60 Mn |
| Mar 31, 2026 | 1.60 Mn |
| Dec 31, 2025 | -376,000.00 |
| Dec 31, 2025 | -376,000.00 |
| Sep 30, 2025 | 110,000.00 |
| Sep 30, 2025 | 110,000.00 |
| Jun 30, 2025 | 542,000.00 |
| Jun 30, 2025 | 542,000.00 |
| Mar 31, 2025 | 2.11 Mn |
| Mar 31, 2025 | 2.11 Mn |
| Dec 31, 2024 | 363,000.00 |
| Dec 31, 2024 | 363,000.00 |
| Sep 30, 2024 | 770,000.00 |
| Sep 30, 2024 | 770,000.00 |
| Jun 30, 2024 | 753,000.00 |
| Jun 30, 2024 | 753,000.00 |
| Mar 31, 2024 | 1.01 Mn |
| Mar 31, 2024 | 1.01 Mn |
| Dec 31, 2023 | 2.36 Mn |
| Dec 31, 2023 | 2.36 Mn |